SEC 13F Intelligence

Claret Asset Management Corp / ABBV

Claret Asset Management Corp’s Abbvie Inc Position

Does Claret Asset Management Corp own Abbvie Inc (ABBV)? Yes115.3K shares worth $25M (+3.00% of its 13F portfolio) as of Q1 2026, down from 116.9K shares the prior filed quarter.

Position Value
$25M
Q1 2026
Shares
115.3K
% of Portfolio
+3.00%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $14MQ4 ’18Q1 ’19: $12MQ2 ’19: $11MQ3 ’19: $11MQ4 ’19: $13MQ4 ’19Q1 ’20: $11MQ2 ’20: $13MQ3 ’20: $12MQ4 ’20: $16MQ4 ’20Q1 ’21: $16MQ2 ’21: $18MQ4 ’21: $23MQ1 ’22: $25MQ1 ’22Q2 ’22: $23MQ3 ’22: $20MQ4 ’22: $24MQ1 ’23: $23MQ1 ’23Q2 ’23: $19MQ3 ’23: $21MQ4 ’23: $22MQ1 ’24: $26MQ1 ’24Q2 ’24: $23MQ3 ’24: $26MQ4 ’24: $23MQ1 ’25: $26MQ1 ’25Q2 ’25: $23MQ3 ’25: $28MQ4 ’25: $27MQ1 ’26: $25MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026115.3K$25M+3.00%
Q4 2025116.9K$27M+3.10%
Q3 2025118.9K$28M+3.28%
Q2 2025122.7K$23M+2.95%
Q1 2025123.5K$26M+3.73%
Q4 2024127.8K$23M+3.59%
Q3 2024130.6K$26M+4.22%
Q2 2024134.2K$23M+4.10%
Q1 2024140.1K$26M+4.29%
Q4 2023142.3K$22M+3.94%
Q3 2023142.8K$21M+4.18%
Q2 2023144.1K$19M+3.79%
Q1 2023145.2K$23M+4.57%
Q4 2022147.3K$24M+5.26%
Q3 2022147.7K$20M+4.70%
Q2 2022149.8K$23M+4.95%
Q1 2022156.0K$25M+4.86%
Q4 2021168.5K$23M+4.22%
Q2 2021157.4K$18M+2.91%
Q1 2021146.9K$16M+2.95%
Q4 2020148.0K$16M+3.13%
Q3 2020135.2K$12M+2.64%
Q2 2020136.3K$13M+3.17%
Q1 2020140.5K$11M+3.02%
Q4 2019146.6K$13M+2.49%
Q3 2019147.2K$11M+2.29%
Q2 2019146.7K$11M+2.21%
Q1 2019147.9K$12M+2.37%
Q4 2018148.2K$14M+3.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Claret Asset Management Corp’s full portfolio or all institutional holders of ABBV.